La découverte de l’ivabradine (Procoralan®), inhibiteur sélectif du courantpacemakerIf: Une nouvelle approche thérapeutique des cardiopathies ischémiques-Reference-Cited by-同舟云学术

La découverte de l’ivabradine (Procoralan®), inhibiteur sélectif du courantpacemakerIf: Une nouvelle approche thérapeutique des cardiopathies ischémiques

Published:2006-01 Issue:1 Volume:22 Page:87-94
ISSN:0767-0974
Container-title:médecine/sciences
language:
Short-container-title:Med Sci (Paris)

Author:

Vilaine Jean-paul

Publisher

EDP Sciences

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.medecinesciences.org/10.1051/medsci/200622187/pdf

Reference53 articles.

1. Holubkov R, Laskey WK, Haviland A,et al.Angina 1 year after percutaneous coronary intervention : a report from the NHLBI Dynamic Registry.Am Heart J2002; 144 : 826–33.

2. Mannheimer C, Camici P, Chester MR,et al.The problem of chronic refractory angina ; report from the ESC Joint Study Group on the Treatment of Refractory Angina.Eur Heart J2002; 23 : 355–70.

3. Steg PG, Dabbous OH, Feldman LJ,et al.Determinants and pronostic impact of heart failure complicating acute coronary syndromes : observations from the Global Registry of Acute Coronary Events (GRACE).Circulation2004; 109 : 494–9.

4. Freemantle N, Cleland J, Young P,et al.β blockade after myocardial infarction : systematic review and meta regression analysis.Br Med J1999; 318 : 1730–7.

5. Dargie HJ, Colucci W, Ford I,et al.Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction : the CAPRICORN randomised trialLancet2001; 357 : 1385–90.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Biological Effects of Ivabradine in Cardiovascular Disease;Molecules;2012-04-30

2. A Novel High-Throughput Screening Assay for HCN Channel Blocker Using Membrane Potential-Sensitive Dye and FLIPR;Journal of Biomolecular Screening;2009-09-22